Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion Concurrent with Radiation Therapy for Locally Advanced Non–Small Cell Lung Cancer

Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion Concurrent with Radiation... The maximally tolerated and recommended phase II paclitaxel dose delivered by protracted continuous infusion is 15 mg/m http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion Concurrent with Radiation Therapy for Locally Advanced Non–Small Cell Lung Cancer

Journal of Thoracic Oncology , Volume 1 (1) – Jan 1, 2006

Loading next page...
 
/lp/wolters-kluwer-health/phase-i-study-of-paclitaxel-given-by-seven-week-continuous-infusion-5sSwb3Dhfk

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1556-0864

Abstract

The maximally tolerated and recommended phase II paclitaxel dose delivered by protracted continuous infusion is 15 mg/m

Journal

Journal of Thoracic OncologyWolters Kluwer Health

Published: Jan 1, 2006

There are no references for this article.